Ledyard National Bank Amgen Inc Transaction History

Ledyard National Bank

$988 Million
Q1 2025

A detailed history of Ledyard National Bank transactions in Amgen Inc stock. As of the latest transaction made, Ledyard National Bank holds 28,700 shares of AMGN stock, worth $8.06 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

28,700

Previous 28,865 0.57%

Holding current value

$8.06 Million

Previous $7.52 Million 18.85%

% of portfolio

0.9%

Previous 0.71%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	SELL	$258.59 - $327.36 $42,667 - $54,014	-165 Reduced 0.57%	28,700 $8.94 Million
Q4 2024 Jan 27, 2025	SELL	$258.78 - $328.31 $510,831 - $648,083	-1,974 Reduced 6.4%	28,865 $7.52 Million
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $170,159 - $185,559	-550 Reduced 1.75%	30,839 $9.94 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $280,879 - $341,342	-1,069 Reduced 3.29%	31,389 $9.81 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $9,410 - $11,359	35 Added 0.11%	32,458 $9.23 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $152,652 - $172,210	597 Added 1.88%	32,423 $9.34 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $28,643 - $35,561	131 Added 0.41%	31,826 $8.55 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $20,998 - $24,830	-98 Reduced 0.31%	31,695 $7.04 Million
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $81,735 - $99,622	-362 Reduced 1.13%	31,793 $7.69 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $185,056 - $235,136	-808 Reduced 2.45%	32,155 $8.45 Million
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $69,807 - $78,729	311 Added 0.95%	32,963 $7.43 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $206,024 - $229,268	-893 Reduced 2.66%	32,652 $7.94 Million
Q1 2022 Apr 25, 2022	BUY	$219.27 - $242.57 $215,980 - $238,931	985 Added 3.03%	33,545 $8.11 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $104,809 - $119,945	527 Added 1.65%	32,560 $7.33 Million
Q3 2021 Oct 20, 2021	BUY	$212.27 - $248.7 $191,255 - $224,078	901 Added 2.89%	32,033 $6.81 Million
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $317,902 - $352,689	-1,361 Reduced 4.19%	31,132 $7.59 Million
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $10,873 - $12,671	-49 Reduced 0.15%	32,493 $8.09 Million
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $60,802 - $72,405	281 Added 0.87%	32,542 $7.48 Million
Q3 2020 Oct 21, 2020	SELL	$234.65 - $260.95 $408,525 - $454,313	-1,741 Reduced 5.12%	32,261 $8.2 Million
Q2 2020 Jul 24, 2020	SELL	$197.81 - $242.74 $6,132 - $7,524	-31 Reduced 0.09%	34,002 $8.02 Million
Q1 2020 Apr 24, 2020	BUY	$182.24 - $241.7 $89,297 - $118,433	490 Added 1.46%	34,033 $6.9 Million
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $105,579 - $135,705	-558 Reduced 1.64%	33,543 $8.09 Million
Q3 2019 Oct 23, 2019	SELL	$174.11 - $208.62 $36,040 - $43,184	-207 Reduced 0.6%	34,101 $6.6 Million
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $61,178 - $71,715	-367 Reduced 1.06%	34,308 $6.32 Million
Q1 2019 Apr 12, 2019	SELL	$180.87 - $203.88 $569,559 - $642,018	-3,149 Reduced 8.33%	34,675 $6.59 Million
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $356,443 - $416,083	1,998 Added 5.58%	37,824 $7.36 Million
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $11,302 - $12,742	-61 Reduced 0.17%	35,826 $7.43 Million
Q2 2018 Jul 11, 2018	BUY	$166.05 - $186.51 $72,563 - $81,504	437 Added 1.23%	35,887 $6.63 Million
Q1 2018 Apr 16, 2018	BUY	$169.43 - $198.0 $64,383 - $75,240	380 Added 1.08%	35,450 $6.04 Million
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $522,067 - $583,308	3,093 Added 9.67%	35,070 $6.1 Million
Q3 2017 Oct 10, 2017	BUY	$167.29 - $191.0 $5.35 Million - $6.11 Million	31,977	31,977 $5.96 Million

Others Institutions Holding AMGN

# of Institutions

3,234

Shares Held

422M

Call Options Held

7.05M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Ledyard National Bank with notifications on news.

Account

Ledyard National Bank Amgen Inc Transaction History